Patients diagnosed with chronic granulomatous disease by the dihydrorhodamine oxidase technique were molecularly and genetically characterized by measuring NADPH oxidase subunit expression and exorne sequencing and analysis. Here, FMO5 is linked to chronic granulomatous disease.